Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.135, Iss.2, 2012-09, pp. : 481-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer

By Curigliano Giuseppe Goldhirsch Aron

Journal of the National Cancer Institute Monographs, Vol. 2011, Iss. 43, 2011-10 ,pp. : 108-110

Oxford University Press

Access to resources Recommend Favorite

Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer

By Kim Sewha

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1681-1694

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic impact of FOXP3 expression in triple-negative breast cancer

By Lee Soohyeon

Acta Oncologica, Vol. 52, Iss. 1, 2013-01 ,pp. : 73-81

Informa Healthcare

Access to resources Recommend Favorite

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer

By Asano Yuka Kashiwagi Shinichiro Goto Wataru Tanaka Sayaka Morisaki Tamami Takashima Tsutomu Noda Satoru Onoda Naoyoshi Ohsawa Masahiko Hirakawa Kosei Ohira Masaichi

Cancers, Vol. 9, Iss. 1, 2017-01 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite

Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2147-2150

Spandidos Publications

Access to resources Recommend Favorite